Torrent Pharma also disclosed that the record date for the dividend is expected to be around February 17, 2025, according to the BSE filling.

India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility.

Torrent Pharmaceuticals posted a 14% rise in profit after tax to Rs 503 crore for Q3 2024, boosted by strong domestic market ...

Torrent Pharma (TRP) delivered largely in line earnings in 3QFY25. The superior performance in domestic formulation (DF) was offset by currency headwinds in Brazil and zero insulin CMO sales.

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...

(Reuters) - India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company, known for ...

On Monday, Citi analyst increased the price target for Torrent Pharma (TRP:IN) to INR4,000, up from INR3,940, while reiterating a Buy rating on the company's shares. The revision follows the ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Citi analyst increased the price target for Torrent Pharma (TRP:IN) to INR4,000, up from INR3,940, while reiterating a Buy ...

JPMorgan analyst updated the financial outlook for Torrent Pharma (TRP:IN), increasing the price target to INR 3,700 from the previous INR 3,400, while keeping a Neutral rating on the stock. The ...

Torrent Pharmaceuticals Ltd share price was up by 1.38% from the previous closing price of ₹3,314.80. Who are peers of Torrent Pharmaceuticals Ltd? The peers of Torrent Pharmaceuticals Ltd are ...